APA:
Copy. (2017). Preoperative neutrophillymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. ONCOTARGET, 8(8), 12891-12901. SID. https://sid.ir/paper/717467/en
Vancouver:
Copy. Preoperative neutrophillymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. ONCOTARGET[Internet]. 2017;8(8):12891-12901. Available from: https://sid.ir/paper/717467/en
IEEE:
Copy, “Preoperative neutrophillymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor,” ONCOTARGET, vol. 8, no. 8, pp. 12891–12901, 2017, [Online]. Available: https://sid.ir/paper/717467/en